Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating heart failure with cardiac contractility modulation electrical signals.

Hani N Sabbah1, Ramesh C Gupta, Sharad Rastogi

  • 1Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA. hsabbah1@hfhs.org

Current Heart Failure Reports
|May 11, 2006
PubMed
Summary

Pharmacologic treatments have improved heart failure (HF) care, but advanced HF still progresses. Device-based therapies, including cardiac contractility modulation (CCM), are emerging as investigational options for advanced HF patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Right Ventricular Metrics as End Points in Clinical Trials: A Review.

JAMA cardiology·2026
Same author

Comprehensive clinical benefit of CCM in HFrEF patients: a win-ratio analysis of FIX-HF-5C randomized trial.

ESC heart failure·2026
Same author

Universal Pulmonary Resistance-Compliance Relationship: And Why It Matters?

Circulation. Heart failure·2026
Same author

De Novo Aortic Insufficiency and Its Progression in Patients on Microaxial Flow Pump Support Before Durable Left Ventricular Assist Device.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions.

Heart failure reviews·2026
Same author

Does Pacemaker Mode Affect Outcomes in Patients With HeartMate 3 LVAD?

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Significant advances in pharmacologic treatment for chronic heart failure (HF) have been achieved over the last two decades.
  • While effective, current medications like ACE inhibitors, beta-blockers, and aldosterone antagonists delay but do not halt the progression of advanced HF.

Purpose of the Study:

  • To review the progress in the development and implementation of cardiac contractility modulation (CCM) as a device-based therapy.
  • To highlight CCM as a potential treatment for patients with advanced heart failure.

Main Methods:

  • Review of existing literature on pharmacologic and device-based therapies for HF.
  • Focus on the development and clinical implementation of CCM devices.

Main Results:

Related Experiment Videos

  • Pharmacologic therapies have reduced mortality and morbidity in HF patients with reduced ejection fraction.
  • Despite optimal medical therapy, many patients with advanced HF continue to deteriorate, necessitating further interventions.
  • Device therapies, including CCM, are emerging to address the unmet needs in advanced HF management.

Conclusions:

  • Cardiac contractility modulation (CCM) is an investigational device-based therapy utilizing electrical signals for advanced HF treatment.
  • CCM represents a promising area of development for managing patients with intractable heart failure.